A common finding between studies investigating the TCR landscape of MDS and AML patients is the fact that naïve CD8+ T cells demonstrate the highest frequency of unique clonotypes, whereas effector CD8+ T cells are characterized by the most contracted phenotype, presenting the lowest degree of distinct clonotypes [146,147,150]. This evidence concerns the gene CD8A and acute myeloid leukemia.